CTI Announces Ira Davis, MD has joined as Medical Director

CTI announces announces Ira Davis, MD has joined as Medical Director. Dr. Davis has significant experience in the clinical development of pharmaceuticals and medical devices, including protocol development, execution, and analysis, as well as more than 30 years of clinical, academic, and industry experience in pediatrics and nephrology. 

80% of CTI Studies Meet or Exceed Enrollment Expectations

Most clinical trials fail to meet enrollment timelines, with more than 3/4 of trials delayed beyond initial projections. At CTI approximately 80% of our studies meet or exceed enrollment expectations, despite the challenging patient populations we work in, including rare diseases and gene therapy trials.

3 out of 4 Sites around the World Prefer CTI to Other CROs

CTI announced the results of the independently commissioned site survey that was sent out earlier this year. Overall, three out of four sites prefer CTI over all other CROs, and nearly 95% of respondents view CTI as equal to or better than other CROs that they have recently worked with.

CTI Announces Community Research to Become CTI Clinical Research Center

CTI announces that Community Research, acquired by CTI earlier this year, will change its name to CTI Clinical Research Center (CTI CRC).


Rare Diseases

Our experience in rare disease research can help efficiently move programs forward.

Learn More

Regulatory Submissions & Applications

CTI’s has continued proven success in numerous approved drug and device applications. We participate in approximately 15% of approved drug applications annually.

Learn More

Clinical Monitoring

With an overall average retention rate of over 95% and decades of industry experience in critical patient populations, our CRAs are able to see their studies through from start-up to close-out.

Learn More

Rare Disease Day 2015

Rare Disease Day

CTI is proud to support Rare Disease Day 2015 - February 28th

Learn More

Clinical Services

Icon Clinical Small Retina

CTI offers the full spectrum of clinical trial services with a proactive and integrated approach.  Our team of operations experts averages more than 14 years of clinical trial and/or patient management experience.

Learn More